Ilaris News
Most Popular Ilaris Story
Novartis' Vasella focuses on rare disease strategy
The recent approval of Novartis' Ilaris for a rare inflammatory disease marks one of the first solid commercial successes for CEO Daniel Vasella's long quest to overhaul the pharma company's Read more...
Latest Headlines
- June 22, 2011
- December 21, 2009
- June 18, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
